CAS 210110-90-0
:3,4,5-Piperidinetriol, 1-butil-2-(hidroximetil)-, clorhidrato (1:1), (2R,3R,4R,5S)-
- 3,4,5-Piperidinetriol, 1-butyl-2-(hydroxymethyl)-, hydrochloride (1:1), (2R,3R,4R,5S)-
- 3,4,5-Piperidinetriol, 1-butyl-2-(hydroxymethyl)-, hydrochloride, (2R,3R,4R,5S)-
- Miglustat HCl
- Miglustat hydrochloride
N-(n-Butyl)-1-deoxynojirimycin hydrochloride
CAS:N-(n-Butyl)-1-deoxynojirimycin hydrochlorideFórmula:C10H21NO4·ClHPureza:>99%Forma y color:Solid-CrystalsPeso molecular:255.738983,4,5-Piperidinetriol, 1-butyl-2-(hydroxymethyl)-, hydrochloride (1:1), (2R,3R,4R,5S)-
CAS:Fórmula:C10H22ClNO4Pureza:98%Forma y color:SolidPeso molecular:255.7390(2R,3R,4R,5S)-1-Butyl-2-(hydroxymethyl)piperidine-3,4,5-triol hydrochloride
CAS:(2R,3R,4R,5S)-1-Butyl-2-(hydroxymethyl)piperidine-3,4,5-triol hydrochlorideFórmula:C10H21NO4·ClHPureza:98%Forma y color:SolidPeso molecular:255.73898Miglustat hydrochloride
CAS:Miglustat hydrochlorideFórmula:C10H22ClNO4Pureza:≥98%Peso molecular:255.742Miglustat HCl
CAS:Fórmula:C10H21NO4·HClForma y color:White To Off-White SolidPeso molecular:219.28 36.46Miglustat HCl
CAS:(2R,3R,4R,5S)-1-Butyl-2-(hydroxymethyl)piperidine-3,4,5-triol hydrochlorideFórmula:C10H22ClNO4Pureza:98%Peso molecular:255.74N-Butyldeoxynojirimycin Hydrochloride
CAS:Producto controladoApplications An inhibitor of a-glucosidase 1 as well as being an inhibitor of HIV cytopathicity. N-Butyldeoxynojirimycin has recently been used to retard lipid storage in the central nervous system of an animal model of Tay-Sachs disease.1-Deoxynojirimycin derivatives as selective inhibitors of glucosylceramide metabolism in man.
References Hettkamp, H., et al.: Eur. J. Biochem., 142, 85 (1984), Szumilo, T., et al.: Arch. Biochem. Biophys., 247, 261 (1986), Fleet, G.W.J., et al.: FEBS Letters, 237, Number 1,2, 128 (1988), Kolter, T., et al.: Angew. Chem. Int. Ed. Engl., 36, 1955 (1997),Fórmula:C10H21NO4·ClHForma y color:NeatPeso molecular:255.74N-Butyldeoxynojirimycin hydrochloride
CAS:Competitive inhibitor of ceramide-glycosyltransferase used for substrate reduction therapy in lysosomal storage disorders. It inhibits glucosylceramide synthase, which catalyses the initial step in glycosphingolipid biosynthetic pathway. This compound delays the onset of symptoms in type 1 Gaucher disease, Sandhoff disease and Tay-Sachs disease. It also reduces brain abnormalities in mucolipidosis type IV.
Fórmula:C10H21NO4•HClPureza:Min. 95%Forma y color:PowderPeso molecular:255.74 g/molMiglustat hydrochloride
CAS:Miglustat hydrochloride (N-Butyldeoxynojirimycin hydrochloride) is an inhibitor of glucosylceramide synthase and can be used for studies about Type I GaucherFórmula:C10H22ClNO4Pureza:99.85%Forma y color:SolidPeso molecular:255.74Ref: TM-TQ0155
1mg38,00€5mg84,00€1mL*10mM (DMSO)93,00€10mg130,00€25mg245,00€50mg385,00€100mg557,00€200mg790,00€









